Good work on the above info. This looks to be why we saw the large buy volumes out of the blue a week or so back. Those kind of buys count in my book. Looking good for more.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%